- Global Pharma News & Resources

Press Releases - 2020-01-22

Date Title Company
22-Jan-2020 New Coastal Group Launches Endo-Aligned(TM) CBD Tinctures and Softgels for Targeted Support
22-Jan-2020 The Center for Breakthrough Medicines is Building the World's Largest Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) to Launch in King of Prussia, PA The Discovery Labs
22-Jan-2020 Neurotrope, Inc. Announces $18 Million Registered Direct Offering Neurotrope, Inc.
22-Jan-2020 US Kidney Dialysis Center Revenues to Advance 4.9% Annually in Nominal Dollars to 2023 The Freedonia Group
22-Jan-2020 KALY - Kali-Extracts Confirms Puration Talks in Strategy to Consolidate on $50 Million Cannabis Biopharmaceutical Technology Business Kali-Extracts, Inc.; Puration, Inc.
22-Jan-2020 Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020 Society for Science & the Public
22-Jan-2020 Forty of the Nation's Brightest Young Scientists Named Finalists in Regeneron Science Talent Search 2020 Regeneron Pharmaceuticals, Inc.
22-Jan-2020 Creek Mountain Partners Responds To Generex Statements Creek Mountain Partners
22-Jan-2020 Contract research firm set to double in size following Northern VCT investment Gentronix Ltd
22-Jan-2020 Freeline to present further FLT180a data at EAHAD Freeline
22-Jan-2020 Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund Seekyo
22-Jan-2020 Myeloma UK London Paris Ride 2020 Launch Myeloma UK
22-Jan-2020 Hansa Biopharma to host conference call to provide Year-End report 2019 and Business Update Hansa Biopharma
22-Jan-2020 Alliance Pharma PLC - Full Year Trading Update Alliance Pharma plc
22-Jan-2020 TISSIUM Recognized as a French Tech 120 Company TISSIUM
22-Jan-2020 Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions Toxys
22-Jan-2020 Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa Abeona Therapeutics
22-Jan-2020 Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease Novartis
22-Jan-2020 Polaryx Therapeutics Receives IND Approval for PLX-200 From the FDA for the Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis Polaryx Therapeutics, Inc
22-Jan-2020 PredictImmune announces commercial partnership with Cambridge Clinical Laboratories (CCL) to promote and supply PredictSURE IBD™, the world’s first validated prognostic test for inflammatory bowel disease PredictImmune